AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

6286_tar_2019-03-07_a6768241-529c-4062-bee0-6a5968c759cb.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2249S

Provident Financial PLC

07 March 2019

7 March 2019

Provident Financial plc

Provident Financial Response to FCA letter to NSF

We note the announcement made by Non-Standard Finance plc (NSF) today disclosing the letter they have received from the FCA.

Provident Financial plc aims to operate at the highest FCA and PRA regulatory standards to ensure good outcomes for customers and attractive, sustainable returns for shareholders.

In the context of the NSF offer, we urge shareholders to take no further action.

Enquiries

Provident, Tel: +44 12 7435 1135

Patrick Snowball, Chairman 

Malcolm Le May, Chief Executive Officer

Gary Thompson / Vicki Turner, Investor Relations, Tel: +44 12 7435 1900

Richard King, Media, Tel: +44 20 3620 3073

Barclays (Joint Lead Financial Adviser and Corporate Broker to Provident) 

Richard Taylor, Tel: +44 20 7623 2323 

Kunal Gandhi 

Francesco Ceccato 

Derek Shakespeare 

J.P. Morgan Cazenove (Joint Lead Financial Adviser and Corporate Broker to Provident) 

Ed Byers, Tel: +44 20 7742 4000 

Jeremy Capstick 

Claire Brooksby 

James Robinson 

Jefferies (Financial Adviser to Provident)

Graham Davidson, Tel: +44 20 7029 8000

Philip Noblet

Barry O'Brien

Brunswick (PR Adviser to Provident) 

Nick Cosgrove, Tel: +44 20 7404 5959 

Charles Pretzlik 

Simone Selzer

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

OFBKMGGFKNKGLZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.